Q: In this task, you're given a paragraph from the research paper and your task is to generate a suitable title for the research paper based on the given paper. Under 100 words is a good title length.
Interferon lambda 4 (IFN4) has been recently known and studied for its role in hepatitis C virus (HCV) infection, but its clinical potential is significantly hampered due to its poor expression in vitro. Our study reports the successful production of IFN4 from a mammalian cell line through a glycoengineering and structure-based approach. We introduced de novo N-glycosylation of IFN4, guided by structural analysis, and produced IFN4 variants in Expi293F that displayed improved expression and potency. To preserve the structure and functionality of IFN4, the model structure of the IFN4 signaling complex was analyzed and the N-glycosylation candidate sites were selected. The receptor binding activity of engineered IFN4 variants and their receptormediated signaling pathway were similar to the E. coli version of IFN4 (eIFN4), while the antiviral activity and induction levels of interferon-stimulated gene (ISG) were all more robust in our variants. Our engineered IFN4 variants may be further developed for clinical applications and utilized in basic research to decipher the immunological roles of IFN4. Previously, the transient expression of wild-type IFN4 in mammalian cells failed to produce significant amounts of recombinant
A:
Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency